The Life Sciences Virtual Investor Forum, co-hosted by B2i Digital, Inc. and Zacks Small-Cap Research, will take place over two days on June 24 and 25, 2026, featuring 22 public companies from sectors including biotechnology, diagnostics, medical devices, and digital health. The event aims to connect investors directly with management teams through live presentations, real-time Q&A, and one-on-one meetings, offering an efficient way to evaluate emerging opportunities in the life sciences space.
B2i Digital, acting as the Official Marketing Partner, will amplify the forum across its platform, leveraging a proprietary network of over 1.7 million retail and institutional market participants. The company has served as the marketing partner for more than 115 investor conferences. According to David Shapiro, Chief Executive Officer of B2i Digital, “Life sciences investors want efficient, direct access to management teams developing the therapies and technologies that matter, and pairing that access with independent research from Zacks makes the forum more valuable on both sides.”
Zacks Small-Cap Research, a preferred provider in the OTC Markets Group's Research Marketplace, brings its team of life sciences analysts to co-host the event, providing independent company-sponsored research to support investor decision-making. The forum will feature 30-minute live presentations followed by Q&A sessions, with replays available on B2i Digital and OTC Markets YouTube channels.
Presenting companies on Day One (June 24) include Protalix BioTherapeutics, MetaVia Inc., CytoSorbents Corporation, PetVivo Holdings Inc., Jaguar Health, Inc., Reviva Pharmaceuticals Holdings, Inc., and 4DMedical Ltd. Day Two (June 25) will feature Prostatype Genomics AB, Abingdon Health plc, Innovotech, Inc., Lakewood-Amedex Biotherapeutics Inc., Nasus Pharma Ltd., Kelyniam Global, Inc., IMUNON, Inc., Promino Nutritional Sciences Inc., Envoy Medical Inc., Coiled Therapeutics plc, Aspire Biopharma Holdings Inc., Rocket Doctor AI Inc., Phio Pharmaceuticals Corp., aTyr Pharma, Inc., and NuFarm Ltd.
Investors can request one-on-one meetings with management teams through the VIC site at this link. Registration and company profiles are available at the event page. For more details about B2i Digital's role, visit their website.
The forum underscores the growing demand for direct investor access to life sciences companies, particularly those in clinical-stage development, rare disease therapeutics, and digital health innovations. By combining live interactions with independent research, the event seeks to bridge information gaps and facilitate informed investment decisions in a sector that often requires specialized knowledge.
